ResMed (RMD) Q4 2026 Earnings Call Transcript

Motley Fool Transcribing, The Motley Fool

Fri, August 14, 2026 astatine 10:13 AM CDT 51 min read

Image source: The Motley Fool.

DATE

Thursday, Aug. 6, 2026 astatine 4:30 p.m. ET

CALL PARTICIPANTS

• Chief Investor Relations Officer-Salli Schwartz

• Chairman and Chief Executive Officer-Mick Farrell

• Chief Financial Officer-Aaron Bloomer

Full Conference Call Transcript

Operator: Hello, and invited to the Q4 Fiscal Year 2026 ResMed Earnings Conference Call. My sanction is Kevin, and I'll beryllium your relation for today's call. At this time, each participants are successful a listen-only mode. Please enactment this league telephone is being recorded. Later, we'll behaviour a question-and-answer session. Let maine manus the telephone implicit to Salli Schwartz, ResMed's Chief Investor Relations Officer. Thanks, Kevin.

Salli Schwartz: I privation to invited our listeners to ResMed's 4th fourth fiscal twelvemonth 2026 Earnings Call. We are unrecorded webcasting this telephone and the replay volition beryllium disposable connected the Investor Relations conception of our firm website aboriginal today. Our net presumption is disposable online now. Please note, we volition beryllium displaying our net presumption during our prepared remarks and past we'll station the slides to our IR website aft the decision of our remarks. During today's call, we volition sermon respective non-GAAP measures that we judge supply utile accusation for investors. This accusation is not intended to beryllium considered successful isolation oregon arsenic a substitute for GAAP fiscal information.

We promote you to reappraisal the supporting schedules successful today's net property merchandise to reconcile these non-GAAP measures with the GAAP reported numbers. In addition, our treatment contiguous volition see forward-looking statements including, but not constricted to, expectations astir our aboriginal fiscal and operating performance, We marque these statements based connected tenable assumptions, However, our net results could differ. Please reappraisal our SEC filings for a implicit treatment of the hazard factors that could origin our existent results to disagree materially from immoderate forward-looking statements. Made today. I'll present crook the telephone implicit to Mick.

Mick Farrell: Thank you, Salli. During the 4th quarter, we delivered different acceptable of beardown results, including: first,

Mick Farrell: 9% maturation successful header gross oregon 8% maturation connected a constant-currency basis. Second, further advancement successful our proviso concatenation ratio initiatives starring to gross borderline enlargement twelvemonth implicit year. Third, a beardown bottommost enactment effect with 16% maturation successful non-GAAP net per share. We closed retired different large fiscal twelvemonth for ResMed connected June 30. For fiscal twelvemonth 2026, our 10% header gross maturation and 180 ground points of operating borderline enlargement drove much than $1.6 cardinal successful escaped currency flow. We usage this superior to put successful our concern some organically inorganically. And to instrumentality much than $1 cardinal to our shareholders done a operation of stock repurchases and dividends. That's an summation of 72% versus the anterior year.